CKD Prediction in HIV+ Patients
Reference point score on equation card
Predicts the 5‑year risk of chronic kidney disease in HIV‑positive adults using the validated D:A:D cohort risk score based on demographic, clinical, and HIV‑related factors 1.
Indikationen
Used in HIV‑positive adults with baseline eGFR > 60 mL/min/1.73 m² to estimate 5‑year CKD risk and guide antiretroviral selection, especially when considering nephrotoxic agents. Identifies patients at low, medium, or high CKD risk based on validated D:A:D cohort data (17,954 participants; CKD incidence 6.2/1,000 PYFU) to support monitoring intensity and avoidance of renal insults 1 [Level I evidence].
Hinweise & Vorsichtsmaßnahmen
Risk depends on age, baseline eGFR, hypertension/diabetes/CVD burden, HCV coinfection, CD4 nadir, and nephrotoxic ART exposure, with higher rates in older, HCV‑coinfected, and CD4‑suppressed patients (D:A:D cohort, 17 954 participants; IRR‑based model) 1. Use cautiously: models underperform in external HIV populations, may misclassify those with AKI, and are sensitive to eGFR variability in Black patients reclassified by race‑free equations 2.